2023 Psychiatry Update NP/PA

A virtual, live, full-day event featuring expert APP presenters. Topics include schizophrenia, tardive dyskinesia, major depression, bipolar depression, and PTSD.

Please note, attendees are asked to select one date, as you can only claim credit for this series once. If you have any questions or need to switch dates, please contact us at customersupport@cealliance.com

To Register: On the Event Dates page click Webinar. On the next screen, please click the blue Register button in upper right-hand corner. Once registered, you will receive a reminder email with a link to join in advance of the event.


*Tentative Agenda

9:00 AM - 9:05 AM: Opening Remarks by Moderator-- Amber Hoberg, MSN, APRN, PMHNP-BC

9:05 AM - 10:05 AM: Avoiding Tardiness When Identifying and Treating Tardive Dyskinesia
Presented by: Amber Hoberg, MSN, APRN, PMHNP-BC

10:05 AM – 10:15 AM: Break

10:15 AM - 11:15 AM: Non-CME Educational Talk

11:15 AM - 11:25 AM: Break

11:25 AM - 12:25 PM: Challenges in Schizophrenia Management
Presented by: Jeremy A. Schreiber, MSN, APRN, PMHNP-BC

12:25 PM - 12:35 PM: Break

12:35 PM - 1:35 PM: Non-CME Educational Talk

1:35 PM – 1:45 PM: Break

1:45 PM – 2:45 PM: A Better Understanding of Bipolar Depression
Presented by: Tina Matthews-Hayes, DNP, CRNP, FNP-BC, PMHNP-BC

2:45 PM – 2:55 PM: Break

2:55 PM – 3:55 PM: Arguments for Augmentation: When to Augment vs Switch Medications in MDD
Presented by: Michael Asbach, DMSc, PA-C, Psych-CAQ

3:55 PM – 4:05 PM: Break

4:05 PM - 5:05 PM: PTSD in the Community
Presented by: Tamar Rodney, PhD, RN, PMHNP-BC, CNE

5:05 PM - 5:15 PM: Closing Remarks by Moderator


Date / Time
Event Details


Michael Asbach, PA

Associate Director
Interventional Psychiatry
DENT Neurologic Institute
Amherst, New York

Amber Hoberg, NP

Jeremy Schreiber, APN/APRN

Goal Statement
The goal of this activity is to improve the knowledge, competence, and performance of learners to assess diagnostic considerations and new and emerging therapies for the treatment of psychiatric illness.

Target Audience
This activity is intended for physician assistants/physician associates and nurse practitioners engaged in the care of patients with psychiatric illness.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Assess latest clinical evidence on new and emerging treatment options for patients with psychiatric disorders
  • Develop individualized treatment strategies for optimal outcomes in patients with psychiatric disorders
  • Discuss best practices in psychiatry to optimize patient care


Credits/Contact Hours are subject to change

 Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 5.0 contact hours, including 5.0 hours of pharmacology credit

Physician Assistant/Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.0 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.